T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Iovance Biotherapeutics
IOVA
$3.05B
| $29.1M | ﹤0.01% |
3,102,912
-379,490
| -11% | -$3.6M |
|
902
Rhythm Pharmaceuticals
RYTM
$8.1B
| $28.8M | ﹤0.01% |
550,530
+24,588
| +5% | +$1.18M |
|
903
Core & Main
CNM
$8.62B
| $28.7M | ﹤0.01% |
646,266
-110,445
| -15% | -$5.29M |
|
904
Choice Hotels
CHH
$4.75B
| $28.6M | ﹤0.01% |
219,437
-4,426
| -2% | -$555K |
|
905
Best Buy
BBY
$17.5B
| $28.6M | ﹤0.01% |
276,726
+13,381
| +5% | +$1.21M |
|
906
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $28.5M | ﹤0.01% |
49,676
+45,612
| +1,122% | +$25.2M |
|
|
CNR
907
Core Natural Resources Inc
CNR
$4.71B
| $28.5M | ﹤0.01% |
271,976
+3,362
| +1% | +$327K |
|
908
Synchrony
SYF
$25.8B
| $28.4M | ﹤0.01% |
569,767
-15,292
| -3% | -$740K |
|
909
Grupo Aeroportuario del Sureste
ASR
$8.24B
| $28.4M | ﹤0.01% |
100,411
+465
| +0.5% | +$133K |
|
910
Invitation Homes
INVH
$17.7B
| $28.4M | ﹤0.01% |
804,783
+13,703
| +2% | +$490K |
|
911
Skyworks Solutions
SWKS
$10.5B
| $28.4M | ﹤0.01% |
287,270
+45,093
| +19% | +$4.78M |
|
912
VeriSign
VRSN
$25.6B
| $28.3M | ﹤0.01% |
149,112
-3,335
| -2% | -$601K |
|
913
BHP
BHP
$222B
| $28.2M | ﹤0.01% |
454,247
+182,162
| +67% | +$10.1M |
|
914
NRG Energy
NRG
$25.4B
| $28.2M | ﹤0.01% |
309,421
+13,419
| +5% | +$1.07M |
|
915
Essential Properties Realty Trust
EPRT
$6.62B
| $28.1M | ﹤0.01% |
823,971
+723,943
| +724% | +$22.4M |
|
916
Host Hotels & Resorts
HST
$15.6B
| $28M | ﹤0.01% |
1,590,067
-1,907,760
| -55% | -$33.1M |
|
917
Robinhood
HOOD
$89.3B
| $27.9M | ﹤0.01% |
1,190,480
-1,682,496
| -59% | -$35.5M |
|
918
Griffon
GFF
$4.75B
| $27.9M | ﹤0.01% |
397,907
+51,435
| +15% | +$3.41M |
|
919
Genuine Parts
GPC
$18.5B
| $27.6M | ﹤0.01% |
197,947
-15
| -0% | -$2.08K |
|
920
Amphastar Pharmaceuticals
AMPH
$850M
| $27.6M | ﹤0.01% |
568,894
-15,012
| -3% | -$659K |
|
921
Ormat Technologies
ORA
$6.97B
| $27.4M | ﹤0.01% |
355,727
-4,904
| -1% | -$364K |
|
922
Atkore
ATKR
$3.17B
| $27.3M | ﹤0.01% |
322,699
-30,039
| -9% | -$3.26M |
|
923
Photronics
PLAB
$1.97B
| $27.3M | ﹤0.01% |
1,104,450
+166,005
| +18% | +$4.02M |
|
924
Tenable Holdings
TENB
$4.08B
| $27.3M | ﹤0.01% |
674,349
-94,310
| -12% | -$3.93M |
|
925
US Foods
USFD
$24B
| $27.3M | ﹤0.01% |
443,733
+206,099
| +87% | +$11.5M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.